This inventor holds 3 USPTO granted patents. Top assignees: Avery Dennison Corporation, Other. Active years: 1993-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1993-1998
Title: Roderick T Coward: Innovator in Medical Technology
Introduction
Roderick T Coward is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of medical technology, particularly in the development of innovative methods for tumor detection and intravenous bottle labeling. With a total of 3 patents to his name, Coward's work exemplifies the intersection of creativity and practicality in healthcare solutions.
Latest Patents
One of Coward's latest patents is a method of using hyaluronic acid for the detection, location, and diagnosis of tumors. This innovative approach involves labeling hyaluronic acid with a diagnostic agent, administering the labeled compound to a patient, and utilizing imaging methods to detect the compound in or on the patient. Another significant patent is for label hangers for intravenous bottles. This invention features a label sheet with hang strips that engage with hooks on intravenous stands, allowing for the suspension of IV bottles upside-down. The design includes break-away ties that hold the hang strips in place until needed, enhancing the efficiency of IV administration.
Career Highlights
Throughout his career, Roderick T Coward has worked with various companies, including Avery Dennison Corporation. His experience in these organizations has contributed to his expertise in medical technology and innovation.
Collaborations
Coward has collaborated with notable individuals in his field, including Kenneth S Lin and Douglas W Wilson. These partnerships have likely fostered a creative environment that has led to the development of his patents.
Conclusion
Roderick T Coward's contributions to medical technology through his patents demonstrate his commitment to improving healthcare solutions. His innovative methods for tumor detection and IV bottle labeling reflect the importance of creativity in addressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile